- EffiX™ is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a comprehensive solution for the development and manufacturing of ...

Plasmid DNA (pDNA) is a fundamental starting material for therapeutic development, including for viral vectors, mRNA therapies, and DNA vaccines. Researchers use capture methods such as anion exchange ...

pRK212.2, a derivative of the broad host range plasmid RK2, contains two EcoRI cleavage fragments, A and B, neither of which can replicate by itself in Escherichia coli. Fragment A (41.7 kilobases), ...

A wide, full shot of the second manufacturing facility on the Aldevron campus. A plasmid DNA manufacturer is planning to scale up its production capacity to meet the growing needs of gene therapy.

To permanently access this eBook for free, fill out the short form below. Manual and automated plasmid purification methods each have their distinct approaches. Manual purification is hands-on and ...

The influence of substrate concentration on plasmid transfer frequency in the rhizosphere was investigated using a physical model employing a hollow fiber membrane instead of a real root. The absolute ...